S&P Keeps Hold on Dell Shares (BusinessWeek)
Plus: Analyst opinions on Intuit and Shire PLC

Reliant Pharmaceuticals Submits New Data To FDA Supporting Use Of Omacor(R) (Omega-3-Acid Ethyl Esters) With A Statin ... (Medical News Today)
Reliant Pharmaceuticalstoday announced a submission to the U.S. Food and Drug Administration (FDA)to seek approval for the expanded use of Omacor(R) (omega-3-acid ethylesters) as an adjunct to diet and statin therapy in adults whosetriglyceride levels are high (200-499 mg/dL). [click link for full article]